Antitumor necrosis factor treatment in patients with inflammatory bowel disease does not promote psoriasis development: A meta-analysis

BACKGROUND: Recent case reports have suggested that anti-tumor necrosis factor (TNF) agents are associated with an increased risk of developing psoriasis in patients with inflammatory bowel disease (IBD). AIMS: This meta-analysis of published studies aimed to evaluate the association between anti-TN...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Yu Kyung, Park, Joo Young, Koh, Seong-Joon, Park, Hyunsun, Kang, Hyoun Woo, Im, Jong Pil, Kim, Joo Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259149/
https://www.ncbi.nlm.nih.gov/pubmed/35801760
http://dx.doi.org/10.1097/MD.0000000000029872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259149/
https://www.ncbi.nlm.nih.gov/pubmed/35801760
http://dx.doi.org/10.1097/MD.0000000000029872

Ejemplares similares